Filing Details
- Accession Number:
- 0001161697-23-000185
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-24 17:00:14
- Reporting Period:
- 2023-03-22
- Accepted Time:
- 2023-03-24 17:00:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402652 | Alicia Grande | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Vp, Treasurer And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2023-03-22 | 3,260 | $0.79 | 53,817 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2023-03-22 | 3,260 | $16.41 | 50,557 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2023-03-22 | 38,524 | $0.79 | 89,081 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2023-03-22 | 38,524 | $16.51 | 50,557 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2023-03-22 | 3,260 | $0.00 | 3,260 | $0.79 |
| Common Stock | Options to purchase common stock | Disposition | 2023-03-22 | 38,524 | $0.00 | 38,524 | $0.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,442,574 | 2023-06-15 | No | 4 | M | Direct | |
| 1,404,050 | 2023-06-15 | No | 4 | M | Direct |
Footnotes
- Shares were sold in various lots from $16.40 to $16.425 per share. The listed sale price represents a weighted average price for the shares sold.
- Shares were sold in various lots from $16.50 to $16.555 per share. The listed sale price represents a weighted average price for the shares sold.
- Shares were sold to cover exercise price of options, tax withholding requirements and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company.
- Options vested in two annual tranches beginning on June 15, 2017.
Billionaire Hedge Funds
